Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
57.36 Down 0.49(0.85%) Jul 11, 3:59PM EDT
Company EventsGet Company Events for:
Upcoming Events 
DateEvent
Aug 4 - Aug 8, 2014 (Est.)Earnings announcement
Recent Events 
DateEvent
2-Jul-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
9-May-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
8-May-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
2-Apr-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
24-Mar-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Shareholder Director Nom
6-Mar-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD D
27-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification t
26-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
20-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
13-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
13-Jan-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq
7-Nov-13ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
6-Nov-13ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
9-Aug-13ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
8-Aug-13ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
10-Jun-13ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders